Five Prime Therapeutics, Inc. To Present At 26th Annual Roth Conference

SOUTH SAN FRANCISCO, Calif., March 5, 2014 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced that Aron Knickerbocker, Chief Business Officer of Five Prime, will present at the 26th Annual Roth Conference on Tuesday, March 11 at 5:30 p.m. Pacific Time. The conference will take place at the Ritz-Carlton Hotel in Laguna Niguel, California.

Help employers find you! Check out all the jobs and post your resume.